Benjamin Graham fit · Investimento deep-value defensivo
Is CytomX Therapeutics, Inc. (CTMX) a Benjamin Graham Stock?
Meets only 3/7 Graham criteria — likely overpriced or unstable.
22/100
FNão encaixa
3/7 critérios atendidos
Os critérios de Benjamin Graham, aplicados a CTMX
P/E ≤ 15
chave—
P/B ≤ 1.5
chave0.0x
Current ratio ≥ 2
3.6x
Debt / Equity ≤ 1
0.0x
Como CTMX pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$969.17M
P/L (TTM)
14.2x
ROIC (TTM)
62.2%
Margem bruta
100.0%
Perguntas frequentes
What is CTMX's Benjamin Graham fit score?
CTMX scores 22/100 on our Benjamin Graham fit engine — grade F. Meets only 3/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own CTMX?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends CTMX.
How often is this score updated?
CTMX's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Benjamin Graham possua ou recomende CTMX pessoalmente.